Analysis of chemical and biological features yields mechanistic insights into drug side effects
- PMID: 23601648
- DOI: 10.1016/j.chembiol.2013.03.017
Analysis of chemical and biological features yields mechanistic insights into drug side effects
Abstract
Side effects (SEs) are the unintended consequence of therapeutic treatments, but they can also be seen as valuable readouts of drug effects, resulting from the perturbation of biological systems by chemical compounds. Unfortunately, biology and chemistry are often considered separately, leading to incomplete models unable to provide a unified view of SEs. Here, we investigate the molecular bases of over 1,600 SEs by navigating both chemical and biological spaces. We identified characteristic molecular traits for 1,162 SEs, 38% of which can be explained using solely biological arguments, and only 6% are exclusively associated with the chemistry of the compounds, implying that the drug action is somewhat unspecific. Overall, we provide mechanistic insights for most SEs and emphasize the need to blend biology and chemistry to surpass intricate phenomena not captured in the molecular biology view.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Systems biology analysis of protein-drug interactions.Proteomics Clin Appl. 2012 Jan;6(1-2):102-16. doi: 10.1002/prca.201100077. Epub 2011 Dec 27. Proteomics Clin Appl. 2012. PMID: 22213655 Review.
-
How advancement in biological network analysis methods empowers proteomics.Proteomics. 2012 Feb;12(4-5):550-63. doi: 10.1002/pmic.201100321. Epub 2012 Jan 19. Proteomics. 2012. PMID: 22247042 Review.
-
Detecting drug targets with minimum side effects in metabolic networks.IET Syst Biol. 2009 Nov;3(6):523-33. doi: 10.1049/iet-syb.2008.0166. IET Syst Biol. 2009. PMID: 19947778
-
Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.Proteomics. 2013 Jan;13(2):313-24. doi: 10.1002/pmic.201200337. Proteomics. 2013. PMID: 23184540
-
Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.J Proteome Res. 2009 May;8(5):2575-85. doi: 10.1021/pr900107z. J Proteome Res. 2009. PMID: 19271732
Cited by
-
Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms.Wiley Interdiscip Rev Syst Biol Med. 2016 Mar-Apr;8(2):104-22. doi: 10.1002/wsbm.1323. Epub 2015 Nov 12. Wiley Interdiscip Rev Syst Biol Med. 2016. PMID: 26559926 Free PMC article. Review.
-
Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects.Nat Commun. 2019 Apr 5;10(1):1579. doi: 10.1038/s41467-019-09407-3. Nat Commun. 2019. PMID: 30952858 Free PMC article.
-
Large-scale identification of adverse drug reaction-related proteins through a random walk model.Sci Rep. 2016 Nov 2;6:36325. doi: 10.1038/srep36325. Sci Rep. 2016. PMID: 27805066 Free PMC article.
-
A chemo-centric view of human health and disease.Nat Commun. 2014 Dec 1;5:5676. doi: 10.1038/ncomms6676. Nat Commun. 2014. PMID: 25435099 Free PMC article.
-
Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database.Drugs Real World Outcomes. 2022 Dec;9(4):639-647. doi: 10.1007/s40801-022-00322-6. Epub 2022 Aug 6. Drugs Real World Outcomes. 2022. PMID: 35933497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical